WELCOME

The Australasian Gastro-Intestinal Trials Group (AGITG) is the only research organisation in the Australasian region with a focus on gastro-intestinal cancers.

Widely known throughout Australasia as the premier meeting in the gastro-intestinal (GI) cancer space, the AGITG Annual Scientific Meeting provides a forum where, on behalf of GI cancer patients, the enigmatic nature of gastro-intestinal cancer is challenged.  The three day program and shared exchange of knowledge is designed to uncover the mysteries of the many cancers that are GI cancer and meet the challenges facing health professionals in the treatment for this group of cancers.

The meeting provides gastro-intestinal cancer clinicians, researchers and allied health specialists with the opportunity to present their research and discuss current challenges and innovations, as well as to hear from international and local leaders on the latest in research and treatments. The meeting also provides an opportunity for involvement of health professionals in the scientific activities of the AGITG.

The program structure includes keynote sessions featuring international guest speakers, plenary and symposia sessions, trials presentations, poster session, new concepts symposium and workshops.

We look forward to seeing you in Melbourne, 25-28 August 2020.

lorraine chantrill

Dr Lorraine Chantrill
AGITG Annual Scientific Meeting Convenor

Russell Conley

Mr Russell Conley
AGITG Chief Executive Officer

Testimonials

A/Prof Manisha Palta
Duke University School of Medicine, USA

A/Prof Manisha Palta

Duke University School of Medicine, USA

The AGITG Annual Scientific Meeting was nothing sort of exceptional. There is true multi-disciplinary integration with medical oncologists, radiation oncologists, surgeons, and the clinical trial portfolio of the AGITG is impressive. Attending this meeting was an excellent experience and I look forward to future opportunities to attend.

Prof Stephen J Wigmore
Royal Infirmary of Edinburgh, The United Kingdom

Professor Wigmore's Headshot

Prof Stephen J Wigmore

Regius Professor of Cinical Surgery

University of Edinburgh

The AGITG Annual Scientific Meeting was a really welcoming environment to discuss advances in treatment of GI cancers. I very much liked the interdisciplinary approach with oncologists, radiation oncologists, surgeon clinical nurse specialists, allied health and client groups all well represented. This meant that there was holistic approach to most discussions. The trial portfolio that the members of AGITG have put together was very impressive and well structured and I liked that the members clearly felt invested in the delivery of good quality trials. The international and local speakers were all excellent and the social programme was very entertaining. All in all a great experience that I look forward to repeating!

Prof Sharlene Gill
BC Cancer, Vancouver, Canada

Prof Sharlene Gill

Medical Oncologist

BC Cancer Centre-Vancouver

I highly recommend the AGITG Annual Scientific Meeting.  During my participation in the 2019 meeting in Adelaide, I was very impressed by the level of engagement and interaction among the attendees and with the faculty.   The quality of the presentations, and expertise within the group contributed to high quality scientific sessions.   I also commend the meeting organizers who created a perfect balance of education, interactive dialogues on clinical trial design and development, and social networking.   If you are involved in the care of patients with GI cancers, you will find the AGITG ASM to be a highly rewarding investment of your time.

Dr Simon Wilkins
Cabrini Monash University

Dr Simon Wilkins

Senior Research Fellow

Cabrini Monash University

Malvern, VIC , Australia

Last August I attended my first AGITG ASM. The conference in Adelaide was a great, well-organised-meeting with excellent international and domestic speakers discussing numerous aspects of colorectal cancer, the microbiome, molecular targets, pancreatic cancer, and current clinical trials. I was thrilled to win the Best of Fast Forward talks which were rapid-fire 3 minutes talks on our poster presentations. I look forward to attending next year’s meeting in Melbourne.

Naomi Knoblauch
Hunter Medical Research Institute

Naomi Knoblauch

Hunter Medical Research Institute

Newcastle, NSW

This was my second AGITG ASM and I was not disappointed.  The quality and relevance of the Study Coordinator sessions was exceptional and provided an excellent opportunity to discuss the unique challenges of trial conduct at sites. I was thrilled also to accept the Outstanding Site ward on behalf of my colleagues in the Medical Oncology Clinical Trials Unit at Calvary Mater Newcastle. The recognition of the contribution of individual trial sites is a wonderful initiative and I encourage all to apply.

Sally Dean
Newcastle Private Hospital, NSW Australia

Sally Dean

Clinical Trial Coordinator

Newcastle Private Hospital

Australia

“I attended the AGITG Annual Scientific Meeting in 2019 for the first time, and found the meeting provided an excellent opportunity to network, especially with other study coordinators.  The meeting was well organised, while the program contained engaging and highly informative sessions. I thoroughly enjoyed the AGITG ASM, finding it interesting and highly relevant for study coordinators.  I look forward to attending many more meetings.”

Dr Mark McGregor
Queen Elizabeth Hospital, South Australia

Dr Mark McGregor

Clinical Research Fellow

Medical Oncology

Queen Elizabeth Hospital

South Australia

“This was my first AGITG meeting and I found it to be a great experience. There was a wide range of topics and expert speakers across surgical and oncological specialties with excellent interactive sessions. The New Concepts Symposium was a great opportunity to present clinical trial proposals and receive real-time feedback, with a clear pathway for further collaboration and development of protocols to get trial ideas off the ground. I will definitely be back for future meetings.”

Prof Christian Jobin
University of Florida, Gainesville

professor christian jobin

Prof Christian Jobin

Gatorade Trust Professor of Medicine
Program Co-leader Cancer Therapeutics and Host Response
University of Florida, Department of Medicine
Division of Gastroenterology

“It was my first experience at the AGITG Annual Scientific Meeting and although I typically do not attend clinical meetings, I was impressed by the quality of this meeting, both with content and expertise of attendees and faculties.  The level of participation from attendees during the “question-answer” period was outstanding and made the meeting very interactive. I had numerous and fruitful interaction with attendees and faculties not only during breaks and hallway encounter but during dinners and receptions. In summary, I was “sold” on this meeting because of both high quality content, expertise of participants and high level of interaction. I highly recommend it.”

 

Prof Florian Lordick
UNIVERSITÄTSKLINIKUM LEIPZIG

Prof Florian Lordick

Direktor Universitäres Krebszentrum Leipzig

“AGITG-2019 was one of the most inspiring GI Cancer experiences I have ever joined. We had lots of discussions and interaction between invited faculty, which was outstanding, and an exceptionally motivated audience. The team from AGITG additionally made it a special experience with their hospitality and perfect organization. I can recommend everyone with an interest in GI cancer treatment and clinical research to join the next AGITG meetings.”

Dr Matthew Burge
Royal Brisbane & Women’s Hospital

Matt Burge

Dr Matthew Burge

Medical Oncologist
Royal Brisbane & Women’s Hospital

Winner of the 2014 Best New Concept Award and recipient of the 2016 Innovation Grant for the MONARCC Study: A randomised Phase II study of panitumumab monotherapy versus panitumumab and 5 Fluorouracil as first line treatment for RAS and RAF wild type metastatic colorectal cancer (mCRC).

“I find the AGITG Annual Scientific Meeting to be an invaluable learning experience. Like many things, what you put in correlates with what you take away. My efforts to submit a new concept proposal were rewarded when it was selected for oral presentation at the New Concepts Symposium at the 2014 meeting. This led to invaluable feedback and ongoing support from the AGITG which has ultimately led to a completed protocol and a study opening to recruitment in March 2018. This is such an exciting outcome for my research career and I have the AGITG to thank for it. The invited faculty is always first class and this meeting provides ample opportunity to network with the faculty (from Australia and overseas) hence learn so much more than just what is delivered in lectures. I can thoroughly recommend attendance at the AGITG Annual Scientific Meeting.”

Prof Andrew Barbour
Princess Alexandra Hospital, Brisbane

Prof Andrew Barbour

Prof Andrew Barbour

Surgeon
Princess Alexandra Hospital, Brisbane

“The AGITG ASM is a multidisciplinary meeting focussed on the current and future management of GI cancer. It provides not only high quality educational material across the spectrum of GI cancer, but encourages the presentation of new clinical trial ideas. Through the New Concepts Symposium, clinical trial concepts are presented and refined for development into national or international studies. The meeting is suitable for trainees and senior clinicians as well as paramedical practitioners engaged in all aspects of GI cancer management.”

Dr Sharon Pattison
University of Otago and Southern District Health Board, Dunedin

Sharon Pattison

Dr Sharon Pattison

Medical Oncologist
University of Otago and Southern District Health Board, Dunedin

“I attended my first AGITG Annual Scientific Meeting as an advanced trainee newly starting a PhD. It was a great educational meeting that had instructive symposia with an interesting and approachable local and international faculty. Those features have been present at each AGITG ASM that I have subsequently attended, and I have found the ASM to be an invaluable forum for presentation of research, less formal discussion of research themes and ideas, and learning about the challenges involved in clinical trial design. The AGITG ASM environment supports collaboration and networking, and I would highly recommend the meeting to all trainees, researchers, investigators and clinicians who have an interest in gastro-intestinal cancers.”

Ms Anne Smith
Canterbury Regional Cancer and Haematology Service

Anne Smith

Ms Anne Smith

Clinical Trials Manager
Christchurch Oncology Research Unit
Canterbury Regional Cancer and Haematology Service

“Key to the AGITG philosophy is a desire to improve the health and quality of life of people with gastro-intestinal cancer by conducting high quality collaborative clinical trials. In developing and conducting these trials the AGITG has successfully encompassed specialists, nurses, research coordinators, scientists, allied health professionals and consumers.

The AGITG Annual Scientific Meeting provides an excellent forum for all these disciplines to come together to share knowledge and experiences and learn from a wide variety of invited international speakers. Incorporated in the meeting are sessions specifically targeting study coordinators and allied health professionals. Speakers and topics for interactive discussion are chosen to complement the annual theme of the meeting and address issues that may arise from a study coordinator perspective.

This is a valuable meeting and excellent opportunity to learn more about clinical trials, changes in medical practice and to exchange ideas and experiences with other study coordinators.”

Dr David Lau
Olivia Newton John Cancer Research Centre

David Lau

Dr David Lau

Clinical Research Fellow
Olivia Newton John Cancer Research Centre

Recipient of the 2018 Merck-AGITG Clinical Research Fellowship

“The AGITG Annual Scientific Meeting is a thoroughly enjoyable conference for all involved in GI cancer. The AGITG have a longstanding commitment to education and invite a high calibre of international and local speakers to deliver an informative program. As an early-career delegate, the conference provided me with a forum to present my research and meet likeminded clinicians, researchers and new collaborators.”

Prof Diana Sarfati
University of Otago, Wellington, New Zealand

Head Shot of Diana Sarfati

Prof Diana Sarfati

Head of Department, Department of Public Health

Professor, Director; Cancer and Chronic Conditions (C3) research group

University of Otago, Wellington, New Zealand

“It was a great pleasure to attend the 2018 AGITG meeting in Brisbane. The conference was vibrant and engaging, with an excellent array of speakers and session types. The programme encouraged collaboration and discussion, with excellent networking opportunities, as well as top notch content. As icing on the cake, the social programme was uniquely hilarious and unlike any other conference I’ve ever been to.”